Expression of the stem cell factor nestin in malignant pleural mesothelioma is associated with poor prognosis

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Thies, Svenja ^a   Friess, Martina ^a   Frischknecht, Lukas ^a   Korol, Dimitri ^a   Felley Bosco, Emanuela ^a   Stahel, Rolf ^a   Vrugt, Bart ^a   Weder, Walter ^a   Opitz, Isabelle ^a   Soltermann, Alex ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; GEMCITABINE; NESTIN; PEMETREXED; PLATINUM COMPLEX; PODOPLANIN; TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; DEOXYCYTIDINE; NES PROTEIN, HUMAN; PLATINUM; POSTN PROTEIN, HUMAN; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; H SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INDUCTION CHEMOTHERAPY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY; TUMOR BIOPSY; UPREGULATION; ADJUVANT CHEMOTHERAPY; ANALOGS AND DERIVATIVES; COHORT ANALYSIS; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; MESOTHELIOMA; METABOLISM; MIDDLE AGED; PLEURAL NEOPLASMS; PROCEDURES; PROGNOSIS; SARCOMA; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NESTIN; PEMETREXED; PLATINUM; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; SARCOMA; STEM CELL FACTOR;

EID: 84947976593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139312     Document Type: Article

References (31)

1. Hinterberger M, Reineke T, Storz M, Weder W, Vogt P, Moch H. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol. 2007; 20(2):248-55. PMID: 17361207
2. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9(4):265-73. doi: 10.1038/nrc2620 PMID: 19262571
3. Yan W, Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem. 2006; 281(28):19700-8. PMID: 16702213
4. Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in nonsmall cell lung cancer. Clin Cancer Res. 2008; 14(22):7430-7. doi: 10.1158/1078-0432.CCR-08-0935 PMID: 19010860
5. Schramm A, Opitz I, Thies S, Seifert B, Moch H, Weder W, et al. Prognostic significance of epithelialmesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2010; 37(3):566-72. doi:10.1016/j.ejcts.2009.08.027 PMID: 19781955
6. Matsui Y, Morimoto J, Uede T. Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction. World J Biol Chem. 2010; 1(5):69-80. doi:10.4331/wjbc.v1.i5.69 PMID: 21540992
7. Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med. 2005; 353(15):1564-73. PMID: 16221779
8. Dubois NC, Hofmann D, Kaloulis K, Bishop JM, Trumpp A. Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues. Genesis. 2006; 44(8):355-60. PMID: 16847871
9. Chen J, Kwon CH, Lin L, Li Y, Parada LF. Inducible site-specific recombination in neural stem/progenitor cells. Genesis. 2009; 47(2):122-31. doi:10.1002/dvg.20465 PMID: 19117051
10. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 2011; 71(8):3098-109. doi:10.1158/0008-5472.CAN-10-3997 PMID: 21393506
11. Lai S, Piras F, Spiga S, Perra MT, Minerba L, Piga M, et al. Nestin and vimentin colocalization affects the subcellular location of glucocorticoid receptor in cutaneous melanoma. Histopathology. 2013; 62(3):487-98. doi:10.1111/his.12018 PMID: 23072594
12. Flammiger A, Besch R, Cook AL, Maier T, Sturm RA, Berking C. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells. J Invest Dermatol. 2009; 129(4):945-53. doi:10.1038/jid.2008.316 PMID: 18923447
13. Asahina K, Tsai SY, Li P, Ishii M, Maxson RE Jr., Sucov HM, et al. Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology. 2009; 49(3):998-1011. doi:10.1002/hep.22721 PMID: 19085956
14. Sakairi T, Hiromura K, Yamashita S, Takeuchi S, Tomioka M, Ideura H, et al. Nestin expression in the kidney with an obstructed ureter. Kidney Int. 2007; 72(3):307-18. PMID: 17429339
15. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010; 466(7308):829-34. doi:10.1038/nature09262 PMID: 20703299
16. Petricevic J, Punda H, Brakus SM, Vukojevic K, Govorko DK, Alfirevic D, et al. Immunolocalization of nestin, mesothelin and epithelial membrane antigen (EMA) in developing and adult serous membranes and mesotheliomas. Acta Histochem. 2012; 114(5):469-79. doi:10.1016/j.acthis.2011.08.009 PMID: 22113177
17. Soltermann A, Kilgus-Hawelski S, Behnke S, Storz M, Moch H, Bode B. Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10. J Clin Bioinforma. 2011; 1:25. doi:10.1186/2043-9113-1-25 PMID: 21961533
18. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004; 15(2):257-60. PMID: 14760119
19. Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, et al. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007; 121(8):1764-70. PMID: 17597110
20. Qin Q, Sun Y, Fei M, Zhang J, Jia Y, Gu M, et al. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer. Neoplasma. 2012; 59(3):310-5. doi:10.4149/neo-2012-040 PMID: 22296500
21. Reimer R, Helmbold H, Szalay B, Hagel C, Hohenberg H, Deppert W, et al. Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. PLoS One. 2009; 4(6):e6084. doi:10.1371/journal.pone.0006084 PMID: 19562035
22. Soltermann A, Pache JC, Vogt P. Metastasis of a pleural mesothelioma to a hyperplastic stomach polyp: an increase of vimentin expression is seen during a gain in deciduoid morphology. Rare tumors. 2011; 3(4):e52. doi:10.4081/rt.2011.e52 PMID: 22355507
23. Frei C, Opitz I, Soltermann A, Fischer B, Moura U, Rehrauer H, et al. Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis. 2011; 32(9):1324-32. doi:10.1093/carcin/bgr127 PMID: 21729925
24. Kobayashi M, Huang CL, Sonobe M, Kikuchi R, Ishikawa M, Imamura N, et al. Snail expression is associated with a poor prognosis in malignant pleural mesotheliomas. Ann Thorac Surg. 2013; 95(4):1181-8. doi:10.1016/j.athoracsur.2013.01.012 PMID: 23453740
25. Iwanami T, Uramoto H, Nakagawa M, Shimokawa H, Yamada S, Kohno K, et al. Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma. Oncology. 2014; 86(2):109-16. doi:10.1159/000356874 PMID: 24457449
26. de Reynies A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N, et al. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin Cancer Res. 2014; 20(5):1323-34. doi:10.1158/1078-0432.CCR-13-2429 PMID: 24443521
27. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. doi:10.1016/j.cell.2008.03.027 PMID: 18485877
28. Scheel C, Weinberg RA. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer. 2011; 129(10):2310-4. doi:10.1002/ijc.26311 PMID: 21792896
29. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Annals of surgical oncology. 2007; 14(12):3629-37. PMID: 17909916
30. Sidi R, Pasello G, Opitz I, Soltermann A, Tutic M, Rehrauer H, et al. Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. Eur J Cancer. 2011; 47(2):326-32. doi:10.1016/j.ejca.2010.09.044 PMID: 21036600
31. Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, et al. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells. Oncogene. 2012; 31(26):3148-63. doi:10.1038/onc.2011.485 PMID: 22020330